BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• Pharm Country

  Avantor® to Participate in Bernstein’s 40th Annual Strategic Decisions Conference

  Avantor, Inc. announced that Michael Stubblefield , President and CEO, will be participating in a fireside chat at Bernstein’s 40th Annual Strategic Decisions Conference in New York.

  May 21, 2024

   · 

  1 min read
• Biotech Beach

  Lineage Announces Updates to 2nd Annual Spinal Cord Injury Investor Symposium

  Lineage Cell Therapeutics, Inc. today announced updates to its 2nd Annual Spinal Cord Injury Investor Symposium (“2nd SCIIS”).

  May 21, 2024

   · 

  7 min read
• Business

  Sunshine Biopharma Reports 2024 First Quarter Results: Revenues Up 54%

  Sunshine Biopharma, Inc. today announced that it has filed its 2024 first quarter report with the Securities and Exchange Commission.

  May 21, 2024

   · 

  3 min read
• Business

  Kronos Bio Appoints Deborah Knobelman, Ph.D. as Chief Operating Officer and Chief Financial Officer

  Kronos Bio, Inc. today announced that it has appointed Deborah Knobelman, Ph.D., as Chief Operating Officer and Chief Financial Officer effective June 3, 2024.

  May 21, 2024

   · 

  3 min read
• BioMidwest

  Cardio Diagnostics to Participate in the Centers for Medicare and Medicaid Services’ (CMS) Clinical Laboratory Fee Schedule (CLFS) Annual Meeting to Secure Medicare Payment for Its Innovative Tests

  Cardio Diagnostics Holdings, Inc. today announced its participation in the Clinical Laboratory Fee Schedule (CLFS) Annual Meeting on June 25, 2024.

  May 21, 2024

   · 

  4 min read
• Genetown

  Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences - May 21, 2024

  Centessa Pharmaceuticals plc today announced that members of its management team will participate in the following investor conferences.

  May 21, 2024

   · 

  1 min read
• Drug Development

  Molecure receives approval to initiate a Phase II clinical trial (KITE) for OATD-01 for the treatment of pulmonary sarcoidosis in selected countries of the European Union and Norway

  Molecure S.A. announces today that it has received national regulatory approvals from Denmark, France, Greece, Germany and Norway to conduct a Phase II clinical trial for OATD-01, a first-in-class chitotriosidase 1 (CHIT1) inhibitor with disease-modifying potential in pulmonary sarcoidosis.

  May 21, 2024

   · 

  6 min read
• Biotech Bay

  Complete Genomics expands to East Coast with new Customer Experience Center in Greater Boston’s Biotech Hub

  Complete Genomics, a pioneering genomic sequencing company, announced the May 22 opening of its Customer Experience Center demonstration lab near Boston’s biotech hub.

  May 21, 2024

   · 

  2 min read
• Business

  Be Biopharma Expands Scientific Advisory Board with the Appointment of Cell and Gene Therapy Leader Dr. Paula Cannon

  Be Biopharma, Inc. today announced the addition of Paula Cannon, Ph.D., to its Scientific Advisory Board.

  May 21, 2024

   · 

  3 min read
• Biotech Bay

  Tempest to Participate in Upcoming Investor Conferences - May 21, 2024

  Tempest Therapeutics, Inc., a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer, announced that management will participate in the following upcoming investor conferences.

  May 21, 2024

   · 

  1 min read